Marieke van Rosmalen

Chapter 8 152 increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429–1436. 64. Morisaki S, Kawai Y, Umeda M, et al. In vivo assessment of peripheral nerve regeneration by diffusion tensor imaging. J. Magn. Reson. Imaging 2011;33:535–542. 65. Poitelon Y, Kopec AM, Belin S. Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism. Cells 2020;9:1–17. 66. Kakuda T, Fukuda H, Tanitame K, et al. Diffusion tensor imaging of peripheral nerve in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A feasibility study. Neuroradiology 2011;53:955–960. 67. Mathys C,Aissa J, Zu Hörste GM, et al. Peripheral Neuropathy: Assessment of Proximal Nerve Integrity By Diffusion Tensor Imaging. Muscle Nerve 2013;48:889–896. 68. Markvardsen LH, Vaeggemose M, Ringgaard S, Andersen H. Diffusion tensor imaging can be used to detect lesions in peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy treated with subcutaneous immunoglobulin. Neuroradiology 2016;58:745– 752. 69. Kronlage M, Pitarokoili K, Schwarz D, et al. DiffusionTensor Imaging inChronic Inflammatory Demyelinating Polyneuropathy: Diagnostic Accuracy and Correlation with Electrophysiology. Invest. Radiol. 2017;52:701–707. 70. Haakma W, Jongbloed BA, Froeling M, et al. MRI shows thickening and altered diffusion in the median and ulnar nerves in multifocal motor neuropathy. Eur. Radiol. 2017;27:2216–2224. 71. Lichtenstein T, Sprenger A, Weiss K, et al. MRI biomarkers of proximal nerve injury in CIDP.Ann. Clin. Transl. Neurol. 2018;5:19–28. 72. Hiwatashi A, Togao O, Yamashita K, et al. Simultaneous MR neurography and apparent T2 mapping in brachial plexus: Evaluation of patients with chronic inflammatory demyelinating polyradiculoneuropathy. Magn. Reson. Imaging 2018;55:112–117. 73. HiwatashiA, Togao O,Yamashita K, et al. Lumbar plexus in patients with chronic inflammatory demyelinating polyradiculoneuropathy: evaluation with simultaneous T2 mapping and neurographymethod with SHINKEI. Br. J. Radiol. 2018;91:20180501. 74. MatthewsWB, Howell DA, HughesRC. Relapsing corticosteroid-dependent polyneuritis. J. Neurol. Neurosurg. Psychiatry 1970;33:330–337. 75. TorvikA, LundarT.Acaseof chronicdemyelinating polyneuropathy resembling the Guillan-Barré Syndrome. J. Neurol. Sci. 1977;32:45–52. 76. Matsuda M, Ikeda SI, Sakurai S, et al. Hypertrophic neuritis due to chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A postmortempathological study. Muscle and Nerve 1996;19:163–169. 77. Auer RN, Bell RB, Lee MA. Neuropathy with Onion Bulb Formations and Pure Motor Manifestations. Can. J. Neurol. Sci. / J. Can. des Sci. Neurol. 1989;16:194–197. 78. Oh SJ, Claussen G, Odabasi Z, Palmer CP. Multifocal demyelinating motor neuropathy: pathologic evidence of `inflammatory demyelinating polyradiculoneuropathy’. Neurology 1995;45:1828–1832. 79. Sasaki M, Ohara S, Oide T, et al. An autopsy case of chronic inflammatory demyelinating polyradiculoneuropathy with respiratory failure. Muscle and Nerve 2004;30:382–387. 80. Koike H, Nishi R, Ikeda S, et al. Ultrastructural mechanisms of macrophage-induced demyelination in CIDP. Neurology 2018;91:1051– 1060. 81. Krarup C, Stewart JD, Sumne AJ, et al. A syndrome of asymmetric limb weakness with motor conduction block. Neurology 1990;40:118– 127. 82. Adams D, Kuntzer T, Steck AJ, et al. Motor conduction block and high titres of anti-GM1 ganglioside antibodies: Pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome. J. Neurol. Neurosurg. Psychiatry 1993;56:982–987. 83. Veugelers B, Theys P, Lammens M, et al. Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block. J. Neurol. Sci. 1996;136:64–70.